Author
The Pirbright InstituteORCID 0000-0002-4450-5911Unclaimed ORCID profile · follow to get notified of new preprints
7 papers
Recent·Most cited
Miriam Pedrera, Nichakorn Pipatpadungsin, Darwyn Kobasa…·Simon Paul Graham
This study isolates and characterizes monoclonal antibodies against Nipah virus from an mRNA-immunized pig, showing their neutralizing activity and potential for therapeutic use.
Rachael Dempsey, Hannah Goldswain, Joseph Newman…·Julian A. Hiscox
This study investigates the phenotypic effects of naturally occurring MERS-CoV Spike mutations on virus entry and neutralisation, identifying mutations that enhance entry or confer resistance to neutralisation.
Ayush Upadhyay, Jeffrey Seow, Yilmaz Alguel…·Katie J. Doores
This study identifies cross-neutralizing mAbs against diverse bat sarbecoviruses and characterizes their conserved epitopes for vaccine design.
Nazia Thakur, Joseph Newman, Dongchun Ni…·Dalan Bailey
This study examines the host range and antigenicity of bat sarbecoviruses, finding that generalist ACE2 users are more related to SARS-CoV-2 and show broader cross-neutralization.
Ariel Isaacs, Guillermo Valenzuela, Xinghai Zhang…·Daniel Watterson
This paper develops a bispecific antibody that targets both Nipah virus surface glycoproteins, reducing viral escape and enhancing protection against NiV disease.
Sam Turner, Gayatri Amirthalingam, Dalan Bailey…·Derek J. Smith
The paper analyzes antibody neutralization data from multiple countries to assess how prior exposure to SARS-CoV-2 variants affects neutralization profiles of BA.2.86 and its descendants.
Cedric C.S. Tan, Jahcub Trew, Thomas P. Peacock…·Vincent Savolainen
The paper screens bat samples for coronaviruses, identifies novel strains, and assesses their potential to infect humans.